The decrease of soluble CD14 levels in patients with adequate response to de novo supplementation of vitamin D may be a hint for such a causal relationship, and previous interventional studies e.g. in patients with hemodialysis or with lung tuberculosis have convincingly shown that vitamin D supplementation can suppress pro-inflammatory cytokine secretion [4,5]. Here, CD14 is linked to pulmonary tuberculosis.